Loading insider details...
Latest Form 4 (Sep 11, 2026): Sale of 131 MDGL shares, $69.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 11, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale | 131 | $69.2K |
| Jul 21, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 50,000 | n/a |
| Mar 6, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 14,995 | n/a |
| Jan 26, 2026 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale | 1,577 | $776.5K |
| Dec 4, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 50,000 | n/a |
| Sep 10, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale | 7,279 | $3.24M |
| Aug 21, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale | 6,485 | $2.59M |
| Mar 7, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Grant/Award | 13,066 | n/a |
| Feb 28, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Exercise/Conversion | 50,000 | n/a |
| Jan 27, 2025 | MADRIGAL PHARMACEUTICALS, INC. (MDGL) | Sale | 1,584 | $531.0K |